1072TiP Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAM×4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumors. - Melero, I.; Lakhani, N.J.; Powderly, J.; Adjei, A.A.; Lopez, J.S.; Paz-Ares, L.G.; Moreno Candilejo, I.; Thistlethwaite, F.; Rohrberg, K.S.; Jerusalem, G.; Malmberg, A.; Ioan-Facsinay, A.; et al. (Annals of Oncology, 2024)